4.37
price up icon2.58%   0.11
after-market Dopo l'orario di chiusura: 4.27 -0.10 -2.29%
loading
Precedente Chiudi:
$4.26
Aprire:
$4.23
Volume 24 ore:
584.87K
Relative Volume:
0.63
Capitalizzazione di mercato:
$288.05M
Reddito:
-
Utile/perdita netta:
$-96.66M
Rapporto P/E:
-2.0326
EPS:
-2.15
Flusso di cassa netto:
$-83.73M
1 W Prestazione:
-6.82%
1M Prestazione:
-17.23%
6M Prestazione:
-25.04%
1 anno Prestazione:
-60.77%
Intervallo 1D:
Value
$4.1206
$4.49
Intervallo di 1 settimana:
Value
$4.1206
$4.7999
Portata 52W:
Value
$2.86
$16.62

Olema Pharmaceuticals Inc Stock (OLMA) Company Profile

Name
Nome
Olema Pharmaceuticals Inc
Name
Telefono
(415) 651-3316
Name
Indirizzo
780 BRANNAN STREET, SAN FRANCISCO
Name
Dipendente
102
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-18
Name
Ultimi documenti SEC
Name
OLMA's Discussions on Twitter

Confronta OLMA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
OLMA
Olema Pharmaceuticals Inc
4.37 288.05M 0 -96.66M -83.73M -2.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-04-02 Iniziato Goldman Buy
2024-01-30 Iniziato Citigroup Buy
2023-07-21 Iniziato Oppenheimer Outperform
2023-05-05 Iniziato CapitalOne Overweight
2023-02-22 Iniziato Credit Suisse Outperform
2022-07-06 Ripresa Canaccord Genuity Buy
2022-06-09 Aggiornamento H.C. Wainwright Neutral → Buy
2022-02-28 Iniziato H.C. Wainwright Neutral
2021-12-07 Ripresa Cowen Outperform
2020-12-14 Iniziato Canaccord Genuity Buy
2020-12-14 Iniziato Cowen Outperform
2020-12-14 Iniziato JP Morgan Overweight
2020-12-14 Iniziato Jefferies Buy
Mostra tutto

Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie

pulisher
Jun 16, 2025

Deeper Dive: Understanding Olema Pharmaceuticals Inc (OLMA) Through its Various Ratios - DWinneX

Jun 16, 2025
pulisher
Jun 13, 2025

Olema Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 12, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail

Jun 10, 2025
pulisher
Jun 10, 2025

Two Sigma Investments LP Has $425,000 Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Jun 10, 2025
pulisher
Jun 07, 2025

Squarepoint Ops LLC Grows Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

HC Wainwright Issues Pessimistic Outlook for OLMA Earnings - MarketBeat

Jun 07, 2025
pulisher
Jun 07, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Acquired by Wellington Management Group LLP - MarketBeat

Jun 07, 2025
pulisher
Jun 05, 2025

Jane Street Group LLC Trims Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Q2 EPS Forecast for Olema Pharmaceuticals Lowered by Analyst - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Two Sigma Advisers LP - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

ProShare Advisors LLC Purchases 3,298 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Ru - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Olema Oncology Expands Team with 322,000 Share Options Grant to New Biotech Talent - Stock Titan

Jun 03, 2025
pulisher
Jun 02, 2025

Deutsche Bank AG Increases Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Bank of America Corp DE Has $5.05 Million Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Jun 01, 2025
pulisher
Jun 01, 2025

Millennium Management LLC Acquires 901,159 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Jun 01, 2025
pulisher
May 31, 2025

H.C. Wainwright Backs Olema Pharmaceuticals (OLMA) as Phase 3 Trials Advance - MSN

May 31, 2025
pulisher
May 29, 2025

H.C. Wainwright maintains Buy on Olema Pharma, $28 target By Investing.com - Investing.com UK

May 29, 2025
pulisher
May 29, 2025

D. E. Shaw & Co. Inc. Cuts Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 29, 2025
pulisher
May 29, 2025

Ameriprise Financial Inc. Has $2.62 Million Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 29, 2025
pulisher
May 28, 2025

Olema Pharmaceuticals, Inc. Announces Palazestrant Dose Selection and Trial-In-Progress Poster at ASCO 2025 Annual Meeting - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Olema Pharmaceuticals (OLMA) Aligns with FDA on Key Dosage for Trials | OLMA Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

FDA Green Lights Crucial Dose for Olema's Advanced Breast Cancer Drug with 2027 Launch Target - Stock Titan

May 28, 2025
pulisher
May 28, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Purchased by Millennium Management LLC - Defense World

May 28, 2025
pulisher
May 28, 2025

Bank of America Corp DE Increases Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 28, 2025
pulisher
May 25, 2025

Northern Trust Corp Buys 34,053 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 25, 2025
pulisher
May 23, 2025

BNP Paribas Financial Markets Makes New $1.13 Million Investment in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

May 23, 2025
pulisher
May 22, 2025

Wall Street Analysts See a 386.42% Upside in Olema Pharmaceuticals (OLMA): Can the Stock Really Move This High? - MSN

May 22, 2025
pulisher
May 22, 2025

Olema Oncology to Participate in Upcoming Investor Conferences - The Manila Times

May 22, 2025
pulisher
May 21, 2025

Olema Oncology Advances Cancer Trials with Strong Financials - TipRanks

May 21, 2025
pulisher
May 21, 2025

Olema Oncology to Participate in Upcoming Investor Conferences | - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Olema Oncology to Participate in Upcoming Investor Conferences | OLMA Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Breast Cancer Biotech Olema Sets Major Presentations at Goldman Sachs and Jefferies Healthcare Conferences - Stock Titan

May 21, 2025
pulisher
May 19, 2025

Paradigm Biocapital Advisors LP Purchases 1,801,370 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

May 19, 2025
pulisher
May 19, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Bought by MPM Bioimpact LLC - MarketBeat

May 19, 2025
pulisher
May 18, 2025

Price T Rowe Associates Inc. MD Has $153,000 Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 18, 2025
pulisher
May 17, 2025

The Goldman Sachs Group Cuts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $18.00 - Defense World

May 17, 2025
pulisher
May 17, 2025

Oppenheimer Cuts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $22.00 - Defense World

May 17, 2025
pulisher
May 17, 2025

Q2 EPS Estimate for Olema Pharmaceuticals Raised by Analyst - Defense World

May 17, 2025
pulisher
May 16, 2025

Voya Investment Management LLC Cuts Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 16, 2025
pulisher
May 16, 2025

Driehaus Capital Management LLC Invests $1.28 Million in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

May 16, 2025
pulisher
May 15, 2025

Analysts Offer Insights on Healthcare Companies: Astria Therapeutics (ATXS), Aquestive Therapeutics (AQST) and Olema Pharmaceuticals (OLMA) - The Globe and Mail

May 15, 2025
pulisher
May 15, 2025

Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Olema Pharmaceuticals (OLMA) Price Target Lowered by Oppenheimer - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Balyasny Asset Management L.P. Increases Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

May 15, 2025
pulisher
May 14, 2025

Olema Pharmaceuticals (OLMA) Price Target Lowered by Goldman Sachs | OLMA Stock News - GuruFocus

May 14, 2025

Olema Pharmaceuticals Inc Azioni (OLMA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Olema Pharmaceuticals Inc Azioni (OLMA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Graham G. Walmsley
Director
Dec 17 '24
Sale
6.75
700,761
4,730,137
0
Zojwalla Naseem
CHIEF MEDICAL OFFICER
Dec 16 '24
Option Exercise
4.87
14,000
68,180
129,509
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):